Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial to Investigate the Pharmacokinetics and ECG Effects of Single Doses of Linaprazan Glurate Administered as Oral Tablets to Healthy Participants

NCT05469854 is registered in ClinicalTrials.gov with Cinclus Pharma Holding AB as lead sponsor.

NCT NCT05469854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05469854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial to Investigate the Pharmacokinetics and ECG Effects of Single Doses of Linaprazan Glurate Administered as Oral Tablets to Healthy Participants
Lead sponsor
Cinclus Pharma Holding AB
Phase
Phase 1
Overall status
Recruiting
Start date
July 13, 2022
Completion date
November 30, 2026
Enrollment
121 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiodynamic ecg, gerd, pharmacokinetics, safety, and tolerability